Medivation (NASDAQ:MDVN) will report earnings after markets close on Thursday, May 9th. Medivation Inc. acquires, develops, and sells or partners biomedical technologies in the early development stage of the research and development process.
Here is your Cheat Sheet to Medivation Earnings:
Earnings Expectations: Analysts expect earnings of $-0.41 per share on revenues of $38.54 million.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.17 to a loss $0.27. For the current year, the average estimate is a loss of $1.11, which is worse than the estimate ninety days ago.
Here’s how Medivation has been performing on an annual basis:
|Revenue ($) in millions||12.58||69.25||62.51||60.39||181.70|
|Diluted EPS ($)||-1.06||-0.855||-0.495||-0.56||-0.56|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||14.94||36.82||42.91||64.80||37.16|
|Diluted EPS ($)||-0.1536||0.005||-0.075||-0.06||-0.4191|
Medivation has missed analyst estimates 3 times in the past four quarters. Shareholders could expect a bust if the company misses estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)